Loading...

Aging Demographics And Genetic Advances Will Unlock Neurological Breakthroughs

Published
11 Apr 25
Updated
07 May 25
AnalystHighTarget's Fair Value
US$247.88
39.6% undervalued intrinsic discount
10 Sep
US$149.61
Loading
1Y
-20.7%
7D
-3.6%

Author's Valuation

US$247.8839.6% undervalued intrinsic discount

AnalystHighTarget Fair Value

Shared on07 May 25
Fair value Decreased 13%

Shared on30 Apr 25
Fair value Decreased 6.36%

AnalystHighTarget has decreased revenue growth from 1.5% to 0.8%.

Shared on23 Apr 25
Fair value Increased 20%

AnalystHighTarget has increased future PE multiple from 15.0x to 18.0x.

Shared on16 Apr 25
Fair value Decreased 0.091%

AnalystHighTarget has increased revenue growth from 0.8% to 1.5%.